Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1791-1794

  Hudnall, S David ^a   Rady, Peter L ^a   Tyring, Stephen K ^a   Fish, Jay C ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN HERPESVIRUS 8; INFECTION RISK; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS ACTIVATION; VIRUS REPLICATION;

ADULT; AGED; DNA, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RISK FACTORS; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES; VIRUS ACTIVATION;

EID: 0031736087     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314482     Document Type: Article

References (14)

1. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
2. Boshoff C, Whitby D, Hatziioannou T, et al. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma [letter]. Lancet 1995;345:1043-1.
3. Dupin N, Grandadam M, Calvez V, et al. Herpes virus-like DNA in patients with Mediterranean Kaposi's sarcoma. Lancet 1995;345:761-2.
4. Rady PL, Hodak E, Yen A, et al. Detection of human herpesvirus-8 DNA in Kaposi's sarcomas from iatrogenically immunosuppressed patients. J Am Acad Dermatol 1998;38:429-37.
5. Decker LL, Shankar P, Khan G, et al. The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 1996;184:283-8.
6. Gao SJ, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996;335:233-11.
7. Miller G, Rigsby MO, Heston L, et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 1996;334:1292-7.
8. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996;2:918-24.
9. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma-associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996;348:1133-8.
10. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996;348:858-61.
11. Smith MS, Bloomer C, Horvat R, Goldstein E, Casparian JM, Chandran B. Detection of human herpes virus 8 DNA in Kaposi's sarcoma lesions and peripheral blood of human immunodeficiency virus-positive patients and correlation with serologic measurements. J Infect Dis 1997;176:84-93.
12. Gao SJ, Kingley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996;2:925-8.
13. Parravicini C, Olsen SJ, Capra M, et. al. Risk of Kaposi's sarcoma-associated herpes virus transmission from donor allografts among Italian post-transplant Kaposi's sarcoma patients. Blood 1997;90:2826-9.
14. Blackbourn DJ, Ambroziak J, Lennette E, Adams M, Ramachandran B, Levy JA. Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 1997;349:609-11.